Expression profiles of EGFR, c-Met, and mTOR/Wnt alternative signaling pathway proteins in non-small cell lung cancer

被引：0
|
作者：
Shearrow, Caleb [1 ]
Crees, Zachary [1 ]
Girard, Jennifer [1 ]
Harrington, Kymberly [1 ]
Arasi, Kavin [1 ]
Bertram, Ceyda [2 ]
Nowak, Andrew [1 ]
Lin, Leo [1 ]
Sheu, Bonnie [1 ]
Palani, Sunil [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med Rockford, Rockford, IL USA
[2] Rensselaer Polytech Inst, Albany, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-743
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
743
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Progress on treatment of MET signaling pathway in non-small cell lung cancer
    Xiaoqing Yu
    Sizhe Yu
    Yun Fan
    International Journal of Clinical Oncology, 2020, 25 : 1450 - 1458
  • [22] Re: The Wnt Signaling Pathway in Non-Small Cell Lung Cancer Response
    Stewart, David J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (08):
  • [23] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    I. Watermann
    B. Schmitt
    F. Stellmacher
    J. Müller
    R. Gaber
    Ch. Kugler
    N. Reinmuth
    R. M. Huber
    M. Thomas
    P. Zabel
    K. F. Rabe
    D. Jonigk
    A. Warth
    E. Vollmer
    M. Reck
    T. Goldmann
    Diagnostic Pathology, 10
  • [24] Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
    Watermann, I.
    Schmitt, B.
    Stellmacher, F.
    Mueller, J.
    Gaber, R.
    Kugler, Ch.
    Reinmuth, N.
    Huber, R. M.
    Thomas, M.
    Zabel, P.
    Rabe, K. F.
    Jonigk, D.
    Warth, A.
    Vollmer, E.
    Reck, M.
    Goldmann, T.
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [25] c-Met Amplification and Protein Expression in Non-Small Cell Lung Cancers.
    Tsuta, K.
    Yoshida, A.
    Tsuda, H.
    MODERN PATHOLOGY, 2011, 24 : 426A - 426A
  • [26] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [27] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [28] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
  • [29] HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer
    Gumustekin, Mukaddes
    Kargi, Aydanur
    Bulut, Gulay
    Gozukizil, Aysim
    Ulukus, Cagnur
    Oztop, Ilhan
    Atabey, Nese
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 209 - 218
  • [30] Profiling c-Met and EGFR kinase inhibitor resistance pathways in non-small lung cancer cells
    Bomgarden, Ryan D.
    Jacobs, Ryan
    Fong, Jason
    Moravec, David
    Botting, Gregory M.
    Blank, Michael
    Viner, Rosa I.
    Rogers, John C.
    Puri, Neelu
    CANCER RESEARCH, 2014, 74 (19)
12345